Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11
Item hits:
Issue DateTitleAuthor(s)
10-Apr-2013miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsPellegrino, L; Stebbing, J; Braga, VM; Frampton, AE; Jacob, J, et al
10-Feb-2016miR-515-5p controls cancer cell migration through MARK4 regulationPardo, OE; Munro, CE; Castellano, L; Hu, Y; Mauri, F, et al
7-May-2013The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept StudyStebbing, J; Payne, R; Reise, J; Frampton, AE; Avery, M, et al
3-Apr-2012The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?Krell, J; Frampton, AE; Stebbing, J; National Institute for Health Research; Cancer Research UK
1-May-2015Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in beta-adrenergic signaling and enhances apoptosisRoca-Alonso, L; Castellano, L; Mills, A; Dabrowska, AF; Sikkel, MB, et al
28-Nov-2014The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach.Badreldin, W; Krell, J; Chowdhury, S; Harland, S; Mazhar, D, et al
13-Jun-2014Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal CancerKrell, J; Frampton, AE; Mirnezami, R; Harding, V; De Giorgio, A, et al
13-Mar-2018Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyCarter, P; Alifrangis, C; Cereser, B; Chandrasinghe, P; Del Bel Belluz, L, et al
13-Mar-2018Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomasCarter, P; Alifrangis, C; Chandrasinghe, P; Cereser, B; Del Bel Belluz, L, et al
25-Oct-2014Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathwayAlshaker, H; Krell, J; Frampton, AE; Waxman, J; Blyuss, O, et al